Patent · US Active

Compositions for stimulation of mammalian innate immune resistance to pathogens

US9186400B2 · kind B2 · utility

4Cited by
98References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 21, 2014
Grant dateNov 17, 2015
Priority date
Expiry dateOct 21, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Embodiments of the invention are directed to methods of treating, inhibiting or attenuating a microbial infection in an individual who has or is at risk for developing such an infection, comprising the step of administering an effective amount of a StIR composition to the individual.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.